{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-015380","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.245485+00:00","generated_at":"2026-06-06T17:25:39.711250+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Inovio Pharmaceuticals effects 1-for-12 reverse stock split effective January 24, 2024","bullets":["Every 12 issued and outstanding shares combined into 1 share; par value unchanged at $0.001.","Fractional shares not issued; stockholders entitled to fractional shares receive cash based on Jan 24 closing price.","Authorized shares of common stock remain at 600,000,000; no reduction.","Proportionate adjustments made to stock options, Series C Convertible Preferred Stock, and equity incentive plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-015380","json":"https://secwatch.observer/filing/0001193125-24-015380.json","markdown":"https://secwatch.observer/filing/0001193125-24-015380.md","text":"https://secwatch.observer/filing/0001193125-24-015380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/0001193125-24-015380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/d736726d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T17:25:39.711250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ef758ab13d847729fc0418fb74189151abdd4cf","claim":"INOVIO PHARMACEUTICALS, INC.: 1-for-12 reverse stock split of common stock effected through certificate of amendment to certificate of incorporation (effective 2024-01-24).","evidence_excerpt":"On January 24, 2024, Inovio Pharmaceuticals, Inc. (the “ Company ”) filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation, as previously amended (the “ Charter Amendment ”) to effect a 1-for-12 reverse stock split of the Company’s common stock (the “ Reverse Stock Split ”). The Reverse Stock Split became effective at 5:00 p.m. Eastern Time on January 24, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/0001193125-24-015380-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}